Vivos Therapeutics (VVOS) Profit After Tax Growth (1y) (2021 - 2026)
Powered by 
Analysis
Vivos Therapeutics (VVOS) Profit After Tax Growth (1y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Align Technology | 11.30 Bn | 10.20 Bn | 757.43 Mn | -13.09% |
| 2 | Envista Holdings | 4.38 Bn | 3.26 Bn | 407.00 Mn | 103.41% |
| 3 | Dentsply Sirona | 2.27 Bn | 2.03 Bn | 493.00 Mn | 182.22% |
| 4 | Milestone Scientific | 37.81 Mn | 35.20 Mn | 1.56 Mn | 57.89% |
| 5 | Dror Ortho-Design | 9.77 Mn | 9.68 Mn | - | 17.67% |
| 6 | Vivos Therapeutics | 2.76 Mn | 790,007.20 | 2.95 Mn | -10.17% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -10.17% |
| Mar 31, 2026 | -100.60% |
| Dec 31, 2025 | -71.20% |
| Sep 30, 2025 | -89.80% |
| Jun 30, 2025 | -159.74% |
| Mar 31, 2025 | -2.68% |
| Dec 31, 2024 | 21.00% |
| Sep 30, 2024 | -37.74% |
| Jun 30, 2024 | 65.09% |
| Mar 31, 2024 | -120.96% |
| Dec 31, 2023 | 29.26% |
| Sep 30, 2023 | 61.48% |
| Jun 30, 2023 | 20.94% |
| Mar 31, 2023 | 68.05% |
| Dec 31, 2022 | 18.18% |
| Sep 30, 2022 | 0.35% |
| Jun 30, 2022 | -72.94% |
| Mar 31, 2022 | -56.84% |
| Dec 31, 2021 | -17.41% |
| Sep 30, 2021 | -200.74% |